United Therapeutics Corporation · NASDAQ:UTHR

Edgemond James sold 10,000 United Therapeutics Corporation shares (Form 4)

Traded Apr 22 to Apr 23, 2026 · Filed Apr 24, 2026

From Apr 22 to Apr 23, 2026, Edgemond James (CFO AND TREASURER) sold 10,000 United Therapeutics Corporation shares at an average US$572.34 for US$5.72M under a trading plan, leaving 18,876 shares. Filed Apr 24, 2026 (Form 4).

Sold
10,000 shares
Price
US$572.34 average (US$569.63 to US$576.62)
Value
US$5.72M
Holding after
18,876 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CFO AND TREASURER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 22, 2026Common StockSale364US$575.8518,996Direct
Apr 23, 2026Common StockOption exercise10,000US$135.4228,876Direct
Apr 23, 2026Common StockSale280US$569.6328,596Direct
Apr 23, 2026Common StockSale1,079US$570.8227,517Direct
Apr 23, 2026Common StockSale3,325US$571.6424,192Direct
Apr 23, 2026Common StockSale3,976US$572.6620,216Direct
Apr 23, 2026Common StockSale321US$573.5119,895Direct
Apr 23, 2026Common StockSale535US$574.7919,360Direct
Apr 23, 2026Common StockSale120US$576.6218,876Direct

Source

View original at SEC

Related